ID   HSP72_HUMAN             Reviewed;         639 AA.
AC   P54652; Q15508; Q53XM3; Q9UE78;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   28-JAN-2026, entry version 220.
DE   RecName: Full=Heat shock-related 70 kDa protein 2;
DE            Short=Heat shock 70 kDa protein 2;
DE   AltName: Full=Heat shock protein family A member 2;
GN   Name=HSPA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7829106; DOI=10.1006/geno.1994.1462;
RA   Bonnycastle L.L.C., Yu C.-E., Hunt C.R., Trask B.J., Clancy K.P.,
RA   Weber J.L., Patterson D., Schellenberg G.D.;
RT   "Cloning, sequencing, and mapping of the human chromosome 14 heat shock
RT   protein gene (HSPA2).";
RL   Genomics 23:85-93(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Goralski T.J., Krensky A.M.;
RL   Submitted (APR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-191 AND GLU-496.
RG   NIEHS SNPs program;
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-126.
RX   PubMed=7849706; DOI=10.1093/hmg/3.10.1819;
RA   Roux A.-F., Nguyen V.T.T., Squire J.A., Cox D.W.;
RT   "A heat shock gene at 14q22: mapping and expression.";
RL   Hum. Mol. Genet. 3:1819-1822(1994).
RN   [7]
RP   INTERACTION WITH FKBP6.
RX   PubMed=18529014; DOI=10.1021/bi8001506;
RA   Jarczowski F., Fischer G., Edlich F.;
RT   "FKBP36 forms complexes with clathrin and Hsp72 in spermatocytes.";
RL   Biochemistry 47:6946-6952(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   METHYLATION AT LYS-564, AND MUTAGENESIS OF LYS-564.
RX   PubMed=23921388; DOI=10.1074/jbc.m113.483248;
RA   Jakobsson M.E., Moen A., Bousset L., Egge-Jacobsen W., Kernstock S.,
RA   Melki R., Falnes P.O.;
RT   "Identification and characterization of a novel human methyltransferase
RT   modulating Hsp70 function through lysine methylation.";
RL   J. Biol. Chem. 288:27752-27763(2013).
RN   [10]
RP   REVIEW.
RX   PubMed=26865365; DOI=10.1007/s12192-016-0676-6;
RA   Radons J.;
RT   "The human HSP70 family of chaperones: where do we stand?";
RL   Cell Stress Chaperones 21:379-404(2016).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 6-386 IN COMPLEX WITH ADP AND
RP   PHOSPHATE.
RX   PubMed=20072699; DOI=10.1371/journal.pone.0008625;
RA   Wisniewska M., Karlberg T., Lehtio L., Johansson I., Kotenyova T.,
RA   Moche M., Schuler H.;
RT   "Crystal structures of the ATPase domains of four human Hsp70 isoforms:
RT   HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B', and HSPA5/BiP/GRP78.";
RL   PLoS ONE 5:E8625-E8625(2010).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of cellular
CC       processes, including protection of the proteome from stress, folding
CC       and transport of newly synthesized polypeptides, activation of
CC       proteolysis of misfolded proteins and the formation and dissociation of
CC       protein complexes. Plays a pivotal role in the protein quality control
CC       system, ensuring the correct folding of proteins, the re-folding of
CC       misfolded proteins and controlling the targeting of proteins for
CC       subsequent degradation. This is achieved through cycles of ATP binding,
CC       ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity
CC       for polypeptides is regulated by its nucleotide bound state. In the
CC       ATP-bound form, it has a low affinity for substrate proteins. However,
CC       upon hydrolysis of the ATP to ADP, it undergoes a conformational change
CC       that increases its affinity for substrate proteins. It goes through
CC       repeated cycles of ATP hydrolysis and nucleotide exchange, which
CC       permits cycles of substrate binding and release (PubMed:26865365).
CC       Plays a role in spermatogenesis. In association with SHCBP1L may
CC       participate in the maintenance of spindle integrity during meiosis in
CC       male germ cells (By similarity). {ECO:0000250|UniProtKB:P17156,
CC       ECO:0000303|PubMed:26865365}.
CC   -!- SUBUNIT: Interacts with FKBP6 (PubMed:18529014). Interacts with ZNF541.
CC       Component of the CatSper complex. Interacts with RABL2/RABL2A; binds
CC       preferentially to GTP-bound RABL2. Interacts with SHCBP1L; this
CC       interaction may promote the recruitment of HSPA2 to the spindle (By
CC       similarity). {ECO:0000250|UniProtKB:P17156,
CC       ECO:0000269|PubMed:18529014}.
CC   -!- INTERACTION:
CC       P54652; Q6DHV7-2: ADAL; NbExp=3; IntAct=EBI-356991, EBI-18899653;
CC       P54652; Q96MA6: AK8; NbExp=3; IntAct=EBI-356991, EBI-8466265;
CC       P54652; Q66PJ3-4: ARL6IP4; NbExp=3; IntAct=EBI-356991, EBI-5280499;
CC       P54652; Q96DX5: ASB9; NbExp=3; IntAct=EBI-356991, EBI-745641;
CC       P54652; Q9UBL3: ASH2L; NbExp=3; IntAct=EBI-356991, EBI-540797;
CC       P54652; Q96FT7-4: ASIC4; NbExp=3; IntAct=EBI-356991, EBI-9089489;
CC       P54652; O95429: BAG4; NbExp=5; IntAct=EBI-356991, EBI-2949658;
CC       P54652; Q8TBE0: BAHD1; NbExp=3; IntAct=EBI-356991, EBI-742750;
CC       P54652; Q9NNX6-10: CD209; NbExp=3; IntAct=EBI-356991, EBI-12300031;
CC       P54652; Q9Y4F5-3: CEP170B; NbExp=3; IntAct=EBI-356991, EBI-12950757;
CC       P54652; Q8WUX9: CHMP7; NbExp=3; IntAct=EBI-356991, EBI-749253;
CC       P54652; Q96EY1-3: DNAJA3; NbExp=3; IntAct=EBI-356991, EBI-11526226;
CC       P54652; Q92782-2: DPF1; NbExp=3; IntAct=EBI-356991, EBI-23669343;
CC       P54652; Q53R41: FASTKD1; NbExp=3; IntAct=EBI-356991, EBI-3957005;
CC       P54652; Q9NSA1: FGF21; NbExp=4; IntAct=EBI-356991, EBI-3909329;
CC       P54652; P15407: FOSL1; NbExp=3; IntAct=EBI-356991, EBI-744510;
CC       P54652; Q06547-2: GABPB1; NbExp=3; IntAct=EBI-356991, EBI-618189;
CC       P54652; Q06547-3: GABPB1; NbExp=3; IntAct=EBI-356991, EBI-9088619;
CC       P54652; Q03933: HSF2; NbExp=3; IntAct=EBI-356991, EBI-2556750;
CC       P54652; Q9NZL4: HSPBP1; NbExp=10; IntAct=EBI-356991, EBI-356763;
CC       P54652; P42858: HTT; NbExp=3; IntAct=EBI-356991, EBI-466029;
CC       P54652; Q0VD86: INCA1; NbExp=3; IntAct=EBI-356991, EBI-6509505;
CC       P54652; Q8N5Z5: KCTD17; NbExp=3; IntAct=EBI-356991, EBI-743960;
CC       P54652; Q6P597: KLC3; NbExp=3; IntAct=EBI-356991, EBI-1643885;
CC       P54652; O43504: LAMTOR5; NbExp=3; IntAct=EBI-356991, EBI-713382;
CC       P54652; Q92615: LARP4B; NbExp=3; IntAct=EBI-356991, EBI-1052558;
CC       P54652; Q99683: MAP3K5; NbExp=3; IntAct=EBI-356991, EBI-476263;
CC       P54652; P30301: MIP; NbExp=3; IntAct=EBI-356991, EBI-8449636;
CC       P54652; Q13562: NEUROD1; NbExp=3; IntAct=EBI-356991, EBI-3908303;
CC       P54652; Q6GQQ9-2: OTUD7B; NbExp=3; IntAct=EBI-356991, EBI-25830200;
CC       P54652; Q8N2H9-4: PELI3; NbExp=3; IntAct=EBI-356991, EBI-25852006;
CC       P54652; O15534: PER1; NbExp=3; IntAct=EBI-356991, EBI-2557276;
CC       P54652; Q58EX7-2: PLEKHG4; NbExp=3; IntAct=EBI-356991, EBI-21503705;
CC       P54652; Q5SXH7-1: PLEKHS1; NbExp=3; IntAct=EBI-356991, EBI-26412802;
CC       P54652; Q14181: POLA2; NbExp=3; IntAct=EBI-356991, EBI-712752;
CC       P54652; Q9H1D9: POLR3F; NbExp=3; IntAct=EBI-356991, EBI-710067;
CC       P54652; P79522: PRR3; NbExp=3; IntAct=EBI-356991, EBI-2803328;
CC       P54652; Q92530: PSMF1; NbExp=3; IntAct=EBI-356991, EBI-945916;
CC       P54652; Q9HD47-3: RANGRF; NbExp=3; IntAct=EBI-356991, EBI-9089733;
CC       P54652; Q9NUC0: SERTAD4; NbExp=3; IntAct=EBI-356991, EBI-1773811;
CC       P54652; Q9UHI5: SLC7A8; NbExp=3; IntAct=EBI-356991, EBI-13292283;
CC       P54652; O14544: SOCS6; NbExp=3; IntAct=EBI-356991, EBI-3929549;
CC       P54652; Q7Z6I5: SPATA12; NbExp=3; IntAct=EBI-356991, EBI-10696971;
CC       P54652; Q496A3: SPATS1; NbExp=3; IntAct=EBI-356991, EBI-3923692;
CC       P54652; P05455: SSB; NbExp=3; IntAct=EBI-356991, EBI-358037;
CC       P54652; O60506-4: SYNCRIP; NbExp=3; IntAct=EBI-356991, EBI-11123832;
CC       P54652; Q7Z7C8-2: TAF8; NbExp=3; IntAct=EBI-356991, EBI-9089028;
CC       P54652; Q8N0U2: TMEM61; NbExp=3; IntAct=EBI-356991, EBI-25830583;
CC       P54652; O00635: TRIM38; NbExp=4; IntAct=EBI-356991, EBI-2130415;
CC       P54652; O60636: TSPAN2; NbExp=3; IntAct=EBI-356991, EBI-3914288;
CC       P54652; P49459: UBE2A; NbExp=3; IntAct=EBI-356991, EBI-2339348;
CC       P54652; Q9NX94: WBP1L; NbExp=3; IntAct=EBI-356991, EBI-10316321;
CC       P54652; Q9BRR0: ZKSCAN3; NbExp=3; IntAct=EBI-356991, EBI-1965777;
CC       P54652; Q15973: ZNF124; NbExp=3; IntAct=EBI-356991, EBI-2555767;
CC       P54652; Q8WUU4: ZNF296; NbExp=3; IntAct=EBI-356991, EBI-8834821;
CC       P54652; Q9BYN7-2: ZNF341; NbExp=3; IntAct=EBI-356991, EBI-16435478;
CC       P54652; Q3KNS6-3: ZNF829; NbExp=3; IntAct=EBI-356991, EBI-18036029;
CC       P54652; Q96BE0; NbExp=2; IntAct=EBI-356991, EBI-9356686;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000250|UniProtKB:P17156}. Note=Colocalizes with SHCBP1L at
CC       spindle during the meiosis process. {ECO:0000250|UniProtKB:P17156}.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known as
CC       the ATPase domain) is responsible for binding and hydrolyzing ATP. The
CC       C-terminal substrate-binding domain (SBD) (also known as peptide-
CC       binding domain) binds to the client/substrate proteins. The two domains
CC       are allosterically coupled so that, when ATP is bound to the NBD, the
CC       SBD binds relatively weakly to clients. When ADP is bound in the NBD, a
CC       conformational change enhances the affinity of the SBD for client
CC       proteins. {ECO:0000305|PubMed:26865365}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L26336; AAA52698.1; -; Genomic_DNA.
DR   EMBL; U56725; AAD11466.1; -; mRNA.
DR   EMBL; BT009815; AAP88817.1; -; mRNA.
DR   EMBL; DQ489378; ABE96830.1; -; Genomic_DNA.
DR   EMBL; BC001752; AAH01752.1; -; mRNA.
DR   EMBL; BC036107; AAH36107.1; -; mRNA.
DR   EMBL; AH006615; AAC50076.1; -; Genomic_DNA.
DR   CCDS; CCDS9766.1; -.
DR   PIR; A55719; A55719.
DR   PIR; I37564; I37564.
DR   RefSeq; NP_001374860.1; NM_001387931.1.
DR   RefSeq; NP_068814.2; NM_021979.3.
DR   PDB; 3I33; X-ray; 1.30 A; A=6-386.
DR   PDB; 4FSV; X-ray; 1.80 A; A=2-387.
DR   PDB; 5FPD; X-ray; 1.97 A; A/B=4-386.
DR   PDB; 5FPE; X-ray; 1.96 A; A/B=4-386.
DR   PDB; 5FPM; X-ray; 1.96 A; A/B=4-386.
DR   PDB; 5FPN; X-ray; 1.96 A; A/B=4-639.
DR   PDBsum; 3I33; -.
DR   PDBsum; 4FSV; -.
DR   PDBsum; 5FPD; -.
DR   PDBsum; 5FPE; -.
DR   PDBsum; 5FPM; -.
DR   PDBsum; 5FPN; -.
DR   AlphaFoldDB; P54652; -.
DR   SMR; P54652; -.
DR   BioGRID; 109538; 602.
DR   CORUM; P54652; -.
DR   ELM; P54652; -.
DR   FunCoup; P54652; 1830.
DR   IntAct; P54652; 368.
DR   MINT; P54652; -.
DR   STRING; 9606.ENSP00000378199; -.
DR   BindingDB; P54652; -.
DR   ChEMBL; CHEMBL2062348; -.
DR   DrugBank; DB04216; Quercetin.
DR   GlyConnect; 1303; 1 N-Linked glycan (1 site).
DR   GlyGen; P54652; 3 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; P54652; -.
DR   MetOSite; P54652; -.
DR   PhosphoSitePlus; P54652; -.
DR   SwissPalm; P54652; -.
DR   BioMuta; HSPA2; -.
DR   DMDM; 1708307; -.
DR   REPRODUCTION-2DPAGE; IPI00007702; -.
DR   jPOST; P54652; -.
DR   MassIVE; P54652; -.
DR   PaxDb; 9606-ENSP00000378199; -.
DR   PeptideAtlas; P54652; -.
DR   PRIDE; P54652; -.
DR   ProteomicsDB; 56690; -.
DR   Pumba; P54652; -.
DR   Antibodypedia; 6; 280 antibodies from 36 providers.
DR   DNASU; 3306; -.
DR   Ensembl; ENST00000247207.7; ENSP00000247207.6; ENSG00000126803.10.
DR   Ensembl; ENST00000394709.2; ENSP00000378199.1; ENSG00000126803.10.
DR   GeneID; 3306; -.
DR   KEGG; hsa:3306; -.
DR   MANE-Select; ENST00000247207.7; ENSP00000247207.6; NM_021979.4; NP_068814.2.
DR   UCSC; uc001xhj.4; human.
DR   AGR; HGNC:5235; -.
DR   ClinPGx; PA29501; -.
DR   CTD; 3306; -.
DR   DisGeNET; 3306; -.
DR   GeneCards; HSPA2; -.
DR   HGNC; HGNC:5235; HSPA2.
DR   HPA; ENSG00000126803; Tissue enhanced (brain, skeletal muscle).
DR   MIM; 140560; gene.
DR   OpenTargets; ENSG00000126803; -.
DR   VEuPathDB; HostDB:ENSG00000126803; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   GeneTree; ENSGT00940000154813; -.
DR   HOGENOM; CLU_005965_3_0_1; -.
DR   InParanoid; P54652; -.
DR   OMA; SYAYNIK; -.
DR   OrthoDB; 2401965at2759; -.
DR   PAN-GO; P54652; 14 GO annotations based on evolutionary models.
DR   PhylomeDB; P54652; -.
DR   PathwayCommons; P54652; -.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-9833482; PKR-mediated signaling.
DR   SignaLink; P54652; -.
DR   SIGNOR; P54652; -.
DR   Agora; ENSG00000126803; Agora Nominated Target for Alzheimer's Disease.
DR   BioGRID-ORCS; 3306; 18 hits in 1158 CRISPR screens.
DR   CD-CODE; 232F8A39; P-body.
DR   CD-CODE; 8C2F96ED; Centrosome.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; DEE660B4; Stress granule.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; HSPA2; human.
DR   EvolutionaryTrace; P54652; -.
DR   GeneWiki; HSPA2; -.
DR   GenomeRNAi; 3306; -.
DR   Pharos; P54652; Tchem.
DR   PRO; PR:P54652; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; P54652; protein.
DR   Bgee; ENSG00000126803; Expressed in inferior vagus X ganglion and 207 other cell types or tissues.
DR   ExpressionAtlas; P54652; baseline and differential.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0036128; C:CatSper complex; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0001673; C:male germ cell nucleus; IEA:Ensembl.
DR   GO; GO:0072687; C:meiotic spindle; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0000795; C:synaptonemal complex; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IBA:GO_Central.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; IEA:InterPro.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0051861; F:glycolipid binding; IEA:Ensembl.
DR   GO; GO:0031072; F:heat shock protein binding; IBA:GO_Central.
DR   GO; GO:0044183; F:protein folding chaperone; IBA:GO_Central.
DR   GO; GO:0051087; F:protein-folding chaperone binding; IEA:Ensembl.
DR   GO; GO:0048156; F:tau protein binding; IEA:Ensembl.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0007141; P:male meiosis I; IEA:Ensembl.
DR   GO; GO:0007140; P:male meiotic nuclear division; TAS:ProtInc.
DR   GO; GO:0090084; P:negative regulation of inclusion body assembly; IDA:UniProtKB.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0042026; P:protein refolding; IDA:UniProtKB.
DR   GO; GO:0009409; P:response to cold; ISS:AgBase.
DR   GO; GO:0009408; P:response to heat; ISS:AgBase.
DR   GO; GO:0006986; P:response to unfolded protein; TAS:ProtInc.
DR   GO; GO:0007286; P:spermatid development; TAS:ProtInc.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   GO; GO:0070194; P:synaptonemal complex disassembly; IEA:Ensembl.
DR   CDD; cd10233; ASKHA_NBD_HSP70_HSPA1; 1.
DR   FunFam; 2.60.34.10:FF:000002; Heat shock 70 kDa; 1.
DR   FunFam; 3.30.420.40:FF:000172; Heat shock 70 kDa protein; 1.
DR   FunFam; 3.90.640.10:FF:000058; Heat shock 70 kDa protein; 1.
DR   FunFam; 1.20.1270.10:FF:000010; Heat shock 70 kDa protein 2; 1.
DR   FunFam; 3.30.30.30:FF:000001; heat shock 70 kDa protein-like; 1.
DR   FunFam; 3.30.420.40:FF:000135; Heat shock cognate 71 kDa protein; 1.
DR   FunFam; 3.30.420.40:FF:000026; Heat shock protein 70; 1.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 3.30.30.30; -; 1.
DR   Gene3D; 3.30.420.40; -; 2.
DR   Gene3D; 3.90.640.10; Actin, Chain A, domain 4; 1.
DR   Gene3D; 2.60.34.10; Substrate Binding Domain Of DNAk, Chain A, domain 1; 1.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   NCBIfam; NF001413; PRK00290.1; 1.
DR   PANTHER; PTHR19375; HEAT SHOCK PROTEIN 70KDA; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF53067; Actin-like ATPase domain; 2.
DR   SUPFAM; SSF100934; Heat shock protein 70kD (HSP70), C-terminal subdomain; 1.
DR   SUPFAM; SSF100920; Heat shock protein 70kD (HSP70), peptide-binding domain; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Chaperone; Cytoplasm; Cytoskeleton;
KW   Differentiation; Methylation; Nucleotide-binding; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Spermatogenesis;
KW   Stress response.
FT   CHAIN           1..639
FT                   /note="Heat shock-related 70 kDa protein 2"
FT                   /id="PRO_0000078258"
FT   REGION          2..389
FT                   /note="Nucleotide-binding domain (NBD)"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   REGION          397..512
FT                   /note="Substrate-binding domain (SBD)"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   REGION          613..639
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        616..631
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         13..16
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         72
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         205..207
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         271..278
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         342..345
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   MOD_RES         403
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P14659"
FT   MOD_RES         408
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P14659"
FT   MOD_RES         414
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P14659"
FT   MOD_RES         564
FT                   /note="N6,N6,N6-trimethyllysine; by METTL21A; in vitro"
FT                   /evidence="ECO:0000269|PubMed:23921388"
FT   VARIANT         191
FT                   /note="C -> S (in dbSNP:rs45456191)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_032706"
FT   VARIANT         496
FT                   /note="K -> E (in dbSNP:rs45447398)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_032707"
FT   MUTAGEN         564
FT                   /note="K->A: Abolishes methylation by METTL21A."
FT                   /evidence="ECO:0000269|PubMed:23921388"
FT   CONFLICT        14
FT                   /note="T -> P (in Ref. 5; AAH36107)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        54
FT                   /note="Missing (in Ref. 6; AAC50076)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        80
FT                   /note="E -> G (in Ref. 5; AAH36107)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        266
FT                   /note="L -> S (in Ref. 2; AAD11466)"
FT                   /evidence="ECO:0000305"
FT   STRAND          8..12
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          14..23
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          26..29
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          37..40
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          43..45
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          50..52
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           54..58
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   TURN            59..62
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           64..66
FT                   /evidence="ECO:0007829|PDB:4FSV"
FT   HELIX           71..73
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   TURN            74..76
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           82..88
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          92..98
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          101..108
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          111..115
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           117..136
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          142..147
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           153..166
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          169..175
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           176..183
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   TURN            184..187
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          191..194
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          197..203
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          208..216
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          219..228
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           233..252
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           260..276
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   TURN            277..279
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          280..291
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          294..301
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           302..308
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           310..315
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           317..327
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           331..333
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   STRAND          336..341
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           342..345
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           347..356
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   TURN            357..359
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   TURN            368..370
FT                   /evidence="ECO:0007829|PDB:3I33"
FT   HELIX           371..383
FT                   /evidence="ECO:0007829|PDB:3I33"
SQ   SEQUENCE   639 AA;  70021 MW;  3851755494E7B729 CRC64;
     MSARGPAIGI DLGTTYSCVG VFQHGKVEII ANDQGNRTTP SYVAFTDTER LIGDAAKNQV
     AMNPTNTIFD AKRLIGRKFE DATVQSDMKH WPFRVVSEGG KPKVQVEYKG ETKTFFPEEI
     SSMVLTKMKE IAEAYLGGKV HSAVITVPAY FNDSQRQATK DAGTITGLNV LRIINEPTAA
     AIAYGLDKKG CAGGEKNVLI FDLGGGTFDV SILTIEDGIF EVKSTAGDTH LGGEDFDNRM
     VSHLAEEFKR KHKKDIGPNK RAVRRLRTAC ERAKRTLSSS TQASIEIDSL YEGVDFYTSI
     TRARFEELNA DLFRGTLEPV EKALRDAKLD KGQIQEIVLV GGSTRIPKIQ KLLQDFFNGK
     ELNKSINPDE AVAYGAAVQA AILIGDKSEN VQDLLLLDVT PLSLGIETAG GVMTPLIKRN
     TTIPTKQTQT FTTYSDNQSS VLVQVYEGER AMTKDNNLLG KFDLTGIPPA PRGVPQIEVT
     FDIDANGILN VTAADKSTGK ENKITITNDK GRLSKDDIDR MVQEAERYKS EDEANRDRVA
     AKNALESYTY NIKQTVEDEK LRGKISEQDK NKILDKCQEV INWLDRNQMA EKDEYEHKQK
     ELERVCNPII SKLYQGGPGG GSGGGGSGAS GGPTIEEVD
//
